Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04603625Not ApplicableCompleted

Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy

Role: collaborator

NCT06472063Recruiting

Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study

Role: collaborator

NCT04867863Completed

SCREENING OF CELIAC DISEASE IN SCHOLAR CHILDREN IN ITALY

Role: collaborator

NCT01513980Not ApplicableCompleted

Life-long Monitoring of COPD in Veneto Region

Role: collaborator

NCT02807688Not ApplicableCompleted

Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses

Role: lead

NCT01513993Not ApplicableCompleted

Remote Monitoring of Chronic Heart Failure in Veneto Region

Role: collaborator

All 6 trials loaded